LINC02175

Across TCGA pan-cancer cohorts, LINC02175 RNA is linked to patient survival in 24 of 34 cancer types, making it the most broadly survival-associated LINC02175 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher LINC02175 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC02175 expression acts as an unfavorable survival marker, although some lineages such as LAML and READ show a favorable association.

BLCA, LAML, and READ are the cancer types where LINC02175 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Median	II,III,IV	0.645	0.766	<.001	99	view →
LAML	DFS	Tertile	All	0.547	0.274	.001	30	view →
READ	OS	Median	II,III,IV	0.848	0.284	.001	27	view →
KIRC	DFS	Quartile	All	0.799	0.484	.002	25	view →
SKCM	OS	Tertile	IV	0.787	0.187	.003	22	view →
BRCA	DFS	Tertile	III,IV	0.840	0.695	.010	20	view →
LUSC	DFS	Tertile	III,IV	0.343	0.961	.002	17	view →
COAD	DFS	Median	All	0.744	0.819	.019	15	view →
THCA	DFS	Median	IV	0.757	0.973	.006	15	view →
KIRP	DFS	Quartile	All	1.000	0.511	.001	15	view →
LUAD	OS	Median	II,III,IV	0.631	0.325	<.001	14	view →
CESC	OS	Median	All	0.838	0.907	.022	14	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 24 lineages.

LINC02175–BLCA (OS)

Open the BLCA breakdown →